Silver Oak Advisory Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Silver Oak Advisory Group's LLY Position: Q2 2026 in Review
Silver Oak Advisory Group reduced its Eli Lilly (LLY) stake by 7.3% in Q2 2026, selling an estimated $31.7K and leaving 394 shares worth $472K. The position accounts for 0.19% of the portfolio, ranked #47.
Silver Oak Advisory Group first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. The position peaked at $585K in Q2 2024. 4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Silver Oak Advisory Group held 394 shares of Eli Lilly worth $472K as of Q2 2026.
- Silver Oak Advisory Group sold 31 Eli Lilly shares in Q2 2026, an estimated $31.7K.
- Eli Lilly made up 0.19% of Silver Oak Advisory Group's portfolio in Q2 2026, its #47 holding.
- Silver Oak Advisory Group first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
- Silver Oak Advisory Group's Eli Lilly position peaked at $585K in Q2 2024.
- 4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Silver Oak Advisory Group's 13F filing for Q2 2026, filed 3 Aug 2026.